Axillary lymph node scarring and the association with tumour response following neoadjuvant chemoendocrine therapy for breast cancer

Breast

Volumn 10, Issue 1, 2001, Pages 61-66

  Donnelly, J ^a   Parham, D M ^a   Hickish, T ^a   Chan, H Y ^a   Skene, A I ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; TAMOXIFEN; TUMOR MARKER;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER STAGING; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OCCULT CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCAR FORMATION; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0035145460     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0219     Document Type: Article

References (20)

1. Results of neoadjuvant chemotherapy and radiation therapy in the breast - Conserving treatment of 250 patients with all stages of infiltrative breast cancer
2. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more
3. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumours larger than 3 cm
4. Preoperative chemotherapy: A model for studying the biology and therapy of primary breast cancer
5. Conservation surgery after primary chemotherapy in large carcinomas of the breast
6. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
7. Primary chemotherapy in surgically resectable breast cancer
8. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
9. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
10. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
11. The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumour biology - An overview of findings
12. Lymph node micrometastases from breast carcinoma
13. Multimodal therapy for locally advanced breast cancer
14. The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue
15. The effects of chemotherapy on morphology, cellular proliferation, apoptosis, and oncoprotein expression in primary breast carcinoma
16. Morphological effects of neoadjuvant chemotherapy in locally advanced breast cancer
17. The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer
18. Effects of chemotherapy on breast cancer tissue
19. Effects of preoperative chemotherapy on morphology of resectable breast carcinoma
20. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy